• About Lareb
    About Lareb
  • Search information about ADRs
    Search information about ADRs
  • Subscribe to newsletter
    Subscribe to newsletter

Updates RSS icon

  • Fatigue associated with biologics
    Fatigue is a common symptom in patients with inflammatory immune diseases. Patients may also experience fatigue as an adverse drug reaction of biologics used for an immune-mediated ...
    Read more
    12 APR
  • Inhalation of small capsule pieces through an inhaler is not harmful
    Puncturing powder capsules for inhalation may cause small capsule pieces to break loose. Capsule pieces that are small enough to pass through the filter are sometimes inhaled when ...
    Read more
    04 APR
  • Guillain-Barré Syndrome after COVID-19 vaccination
    Until October 12th 2022, the Netherlands Pharmacovigilance Centre Lareb received 72 reports of  Guillain-Barré Syndrome (GBS) following COVID-19 vaccination. GBS is labeled as a ra ...
    Read more
    10 MAR
  • Propylthiouracil and ANCA vasculitis
    The Netherlands Pharmacovigilance Centre Lareb received seven well-documented reports on propylthiouracil and anti-neutrophil cytoplasmic antibody (ANCA) positive vasculitis. Prop ...
    Read more
    15 FEB
  • Call for abstracts for the ISoP Mid-Year Symposium 2023
    This year the ISoP mid-year meeting will be hosted by the Netherlands Pharmacovigilance Centre Lareb on 1-2 June 2023 in Leiden, the Netherlands. This meeting will focus on connect ...
    Read more
    13 FEB
  • Higher probability of experiencing a side effect in women after COVID-19 vaccination
    Females have a two-fold higher odds of experiencing an adverse event following immunization (AEFI) than males after a COVID-19 vaccination. This difference was greater after the fi ...
    Read more
    07 FEB